The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,181.00
Bid: 1,172.00
Ask: 1,181.00
Change: 7.00 (0.60%)
Spread: 9.00 (0.768%)
Open: 1,170.00
High: 1,183.00
Low: 1,170.00
Prev. Close: 1,174.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Jul 2015 07:00

RNS Number : 0894U
Fevertree Drinks PLC
27 July 2015
 



27th July 2015

 

Fevertree Drinks plc ("Fever-Tree")

 

Interim Results

 

Fever-Tree, the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, today announces its Interim Results for the period ended 30 June 2015.

 

Financial Highlights:

 

· Revenue up 62% to £24.1m (H1 2014: £14.9m)

· Gross margin of 50.5% (H1 2014: 51.1%)

· Adjusted EBITDA1 up 68% to £7.2m (H1 2014: £4.3m)

· Strong balance sheet with net cash at period end of £7.9m

· Diluted EPS of 4.44 pence

· Interim dividend of 0.78 pence per share

 

Operational Highlights:

 

· New UK Off-Trade listing in Morrisons

· Continued strong growth in Ginger Beer sales in USA

· Launch of the new 150ml can format

 

Tim Warrillow, CEO of Fever-Tree said:

 

"We are delighted to report that the Group's strong performance throughout 2014 has continued into the first half of 2015. We achieved a 62% increase in revenue with all four of our territories continuing to perform strongly and the results were underpinned by solidly maintained margins and a strong balance sheet.

 

The Group remains ideally positioned to benefit from the ongoing global trend to greater premiumisation and look to the future with confidence as we continue to deepen our penetration in our existing markets whilst exploring new market opportunities."

 

1 Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, exceptional items and finance costs

 

For further information:

 

Fevertree Drinks plc

c/o FTI +44 (0)20 3727 1000

Tim Warrillow, Co-founder and CEO

Charles Rolls, Co-founder and Executive Deputy Chairman

Andy Branchflower, Finance Director

FTI Consulting - Financial PR

+44 (0)20 3727 1000

Jonathon Brill

fever-tree@fticonsulting.com

Oliver Winters

Tom Hufton

Investec Bank plc - Nominated Adviser and Broker

+44 (0)20 7597 4000

Garry Levin

Duncan Williamson

Matt Lewis

David Anderson

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). Approximately 70 per cent of the Group's sales were derived from outside of the UK in financial year 2014, with key overseas markets in the US and Europe.

 

Chief Executive's report

I am delighted to report that the Group's strong performance in 2014 has continued in the first half of 2015. During the period we achieved revenue of £24.1m, representing growth of 62% on the first half of 2014.

 

Despite some net forex headwinds, our gross profit margin has been maintained at 50.5% (2014: 51.1%) and the Group achieved an adjusted EBITDA of £7.2m in the first half of the year, generating diluted earnings per share of 4.44p. We begin the second half of 2015 with a strong balance sheet and net cash of £7.9m.

 

Results

 

Half year ended 30 June 2015

Half year ended 30 June 2014

Movement

£m

£m

%

Revenue

24.1

14.9

62%

Gross Profit

12.1

7.6

60%

Gross Profit %

50.5%

51.1%

Adjusted EBITDA

7.2

4.3

68%

Adjusted EBITDA %

29.9%

28.9%

Diluted EPS

4.44

16.792

Interim Dividend

0.78p

n/a

 

2 Calculation based on pre-IPO structure, see notes to the financials

 

 

Territory review

Revenue by territory

Half year ended 30 June 2015

Half year ended 30 June 2014

Movement

Share of revenue

£m

£m

%

%

UK

7.6

4.7

62%

32%

USA

5.8

3.5

69%

24%

Europe

9.4

5.8

61%

39%

RoW

1.3

0.9

42%

5%

Total

24.1

14.9

62%

100%

 

UK

 

In our largest market, the Group achieved sales growth of 62%, with strong performance in both the On-Trade and Off-Trade, although this result was accentuated by certain customers building inventory in June in advance of the summer season. In the first half of 2015 we increased investment in the On-Trade sales team and achieved some notable new listings. In the Off-Trade we also gained a listing with Morrisons. Our new tonic and naturally light tonic in 150ml can format was launched in Sainsbury's at the very end of June, in Waitrose in July and was soon followed by an exclusive listing in British Airways First Class and Club World cabins as well as lounges throughout the UK.

 

USA

 

The strong momentum from 2014 has continued, with revenue growth of 69% in the period, which represented growth of 54% when adjusted for the strengthening US dollar. The "Moscow Mule" trend continued to drive growth in Ginger Beer sales in the first half of the year although growth across the Tonic flavours is also notable reflecting the rise in popularity of a premium gin and tonic in the region.

 

Europe

 

Revenue growth of 61% was achieved in the period, which represented growth of 77% when adjusted for the weakening Euro. Whilst this strong result was aided by certain importers taking large orders in June in advance of the summer season, growth continues to be underpinned by the strong performance seen in 2014 across many western European countries which has continued into the first half of 2015.

 

RoW

 

Sales to countries within the RoW region have grown by 42% and the Group has added dedicated resource to take advantage of opportunities in Asia Pacific and Latin America.

 

Financial

Gross margin and operating expenses

 

Gross margin of 50.5% in the period represents a decrease from the 51.1% achieved in the first half of 2014. The main driver of this decrease was the weakening Euro, although this has been partially offset by the impact of the strengthening Dollar, as well as product cost and logistics efficiencies.

 

Underlying operating expenses1 decreased as a proportion of revenue to 20.4% during the period (2014: 22.3%), which has improved the EBITDA margin to 29.9% (2014: 28.9%). For the current period underlying operating expenses include an incremental £0.4m unrealised gain made on outstanding forward exchange contracts at June 2015. Disregarding this £0.4m unrealised gain, the level of other underlying operating expenses is comparable to the prior period at 22.2% of revenue (2014: 22.3%).

 

Cash position and working capital

 

The Group had net cash of £7.9m at period end, with £14.0m of cash at the bank offset by £6.1m of bank loans. Adjusted operating cash flow in the period is strong at 83% of adjusted EBITDA, albeit this conversion rate is influenced by seasonality and is expected to return to levels seen historically as we progress through 2015.

 

Dividend

Reflecting the Board's continued confidence in the outlook, the Directors are pleased to declare an interim dividend of 0.78 pence per share. The dividend will be paid on 4 September 2015, to shareholders on the register on 14 August 2015.

 

Outlook

 

We are encouraged by our performance in the first half of the year and the Board remains positive about the outlook for 2015.

 

 

__________________

 

1Underlying operating expenses are defined as administrative expenses less LTIP charges, depreciation, amortisation and exceptional items

 

 

Tim Warrillow

Chief Executive

 

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 30 June 2015

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

2015

2014

2014

Note

£

£

£

Revenue

2

24,069,646

14,868,371

34,691,034

Cost of sales

(11,921,618)

(7,264,829)

(17,028,408)

Gross profit

12,148,028

7,603,542

17,662,626

Administrative expenses

(5,366,114)

(3,862,770)

(9,574,793)

Adjusted EBITDA*

7,196,899

4,291,027

10,005,110

Depreciation

(54,985)

(35,481)

(84,263)

Amortisation

(360,000)

(357,041)

(717,041)

Exceptional items

-

(157,733)

(1,115,973)

Operating profit

6,781,914

3,740,772

8,087,833

Finance costs

Finance income

5,023

5,167

9,222

Finance expense

(193,767)

(2,619,209)

(5,575,813)

Profit before tax

6,593,170

1,126,730

2,521,242

Tax expense

(1,435,758)

(471,615)

(1,224,831)

Profit for the year/period and comprehensive income attributable to equity holders of the parent company

5,157,412

 

655,115

1,296,411

Earnings per share for profit attributable to the owners of the parent during the year

Basic (pence)

4

4.48

16.79

1.54

Diluted (pence)

4

4.44

16.79

1.54

 

* Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, exceptional items and finance costs

 

 

 

 

Consolidated statement of financial position

30 June 2015

 

30 June

30 June

31 December

2015

2014

2014

£

£

£

Non-current assets

Property, plant and equipment

411,164

330,369

351,699

Intangible assets

44,210,655

44,930,655

44,570,655

Total non-current assets

44,621,819

45,261,024

44,922,354

Current assets

Inventories

5,391,968

3,310,848

4,346,168

Trade and other receivables

10,764,817

7,586,737

8,390,202

Derivative financial instruments

458,054

42,124

11,051

Cash and cash equivalents

13,975,803

3,936,707

9,583,313

Total current assets

30,590,642

14,876,416

22,330,734

Total assets

75,212,461

60,137,440

67,253,088

Current liabilities

Trade and other payables

6,983,416

3,932,790

4,387,498

Derivatives

-

495

-

Loans and borrowings

634,784

291,033

364,445

Corporation tax liability

1,413,894

782,128

658,604

Total current liabilities

9,032,094

5,006,446

5,410,547

Non-current liabilities

Loans and borrowings

5,461,339

53,365,413

5,895,828

Deferred tax liability

2,607,661

2,584,218

2,679,661

Total non-current liabilities

8,069,000

55,949,631

8,575,489

Total liabilities

17,101,094

60,956,077

13,986,036

Net assets / (liabilities)

58,111,367

(818,637)

53,267,052

Equity attributable to equity holders of the company

Share capital

288,102

281,321

288,102

Share premium

53,521,386

186,796

53,521,386

Capital Redemption Reserve

93,189

-

93,189

Retained earnings

4,208,690

(1,286,754)

(635,625)

Total equity

58,111,367

(818,637)

53,267,052

 

 

 

 

Consolidated statement of cash flows

For the six months ended 30 June 2015

Period ended

Period ended

Year ended

30 June

30 June

31 December

2015

2014

2014

£

£

Operating activities

Profit before tax

6,593,170

1,126,730

2,521,242

Finance expense

193,767

2,619,209

5,575,813

Finance income

(5,023)

(5,167)

(9,222)

Depreciation of property, plant and equipment

54,985

35,481

84,263

Amortisation of intangible assets

360,000

357,041

717,041

Share based payments

32,626

-

9,833

7,229,525

4,133,294

8,898,970

(Increase)/Decrease in trade and other receivables

(2,829,534)

(1,590,352)

(2,401,730)

(Increase)/Decrease in inventories

(1,045,800)

(769,075)

(1,804,395)

Increase/(Decrease) in trade and other payables

2,595,918

1,031,312

1,482,143

(1,279,416)

(1,328,115)

(2,723,982)

Cash generated from operations before exceptional items

5,950,109

2,962,912

7,290,961

Exceptional items

-

(157,733)

(1,115,973)

Cash generated from operations

5,950,109

2,805,179

6,174,988

Income taxes paid

(752,469)

(538,825)

(1,320,121)

Net cash flows from operating activities

5,197,640

2,266,354

4,854,867

Investing activities

Purchase of property, plant and equipment

(114,450)

(197,610)

(267,723)

Net cash used in investing activities

(114,450)

(197,610)

(267,723)

Financing activities

Interest (paid)

(152,893)

(1,315,223)

(1,459,545)

Interest received

7,916

5,168

9,222

Loans repaid

(200,000)

(175,000)

(350,000)

Loan note repaid

-

-

(49,991,087)

Shares issued (net of fees allocated against equity)

-

-

53,434,561

Dividends paid

(345,723)

-

-

Net cash used in financing activities

(690,700)

(1,485,055)

1,643,151

Net increase in cash and cash equivalents

4,392,490

583,689

6,230,295

Cash and cash equivalents at beginning of period

9,583,313

3,353,018

3,353,018

Cash and cash equivalents at end of period

13,975,803

3,936,707

9,583,313

Notes to the consolidated financial statements

For the six months ended 30 June 2015

 

1. Basis for preparation

The interim financial statements have been prepared in accordance with the recognition and measurement requirements of International Financial Reporting Standards (IFRS) and IFRIC interpretations issued by the International Accounting Standards Board (IASB) adopted by the European Union.

The accounts have been prepared in accordance with accounting policies that are consistent with the December 2014 Report and Accounts and that are expected to be applied in the Report and Accounts of the year ended 31 December 2015. There are new or revised standards or interpretations that apply to the period beginning 1 January 2015 but they do not have a material effect on the financial statements for the period ended 30 June 2015.

This report is not prepared in accordance with IAS 34, which is not mandatory. The financial information does not constitute statutory accounts within the meaning of section 435 of the Companies Act 2006. Statutory accounts for Fevertree Drinks Plc for the year ended 31 December 2014 have been delivered to the Registrar of Companies. The auditors' report on those accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006.

2. Revenue

An analysis of turnover by geographical market is given below:

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

2015

2014

2014

£

£

£

United Kingdom

7,590,177

4,691,241

11,138,177

United States of America

5,809,368

3,446,272

8,286,535

Europe

9,408,768

5,844,416

13,438,075

Rest of the World

1,261,333

886,442

1,828,247

24,069,646

14,868,371

34,691,034

 

3. Dividends

The interim dividend of 0.78p will be paid on 4 September 2015 to shareholders on the register on 14 August 2015.

 

4. Earnings Per Share

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

2015

2014

2014

£

£

£

Profit

Profit used in calculating basic and diluted EPS

5,157,412

655,115

1,296,411

Number of shares

Weighted average number of shares for the purpose of

basic earnings per share

115,240,896

 

3,900,979

 

83,934,200

Weighted average number of employee share options outstanding

842,531

-

133,882

Weighted average number of shares for the purpose of

diluted earnings per share

116,083,427

3,900,979

84,068,082

Basic earnings/(loss) per share (pence)

4.48

16.79

1.54

Diluted earnings/(loss) per share (pence)

4.44

16.79

1.54

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR QZLFLEDFLBBL
Date   Source Headline
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM
25th May 20237:00 amRNSBoard Changes
25th May 20237:00 amRNSAGM Trading Statement
12th May 202311:25 amRNSHolding(s) in Company
5th May 20237:00 amRNSGrant of Options
2nd May 20237:00 amRNSTotal Voting Rights
21st Apr 20231:08 pmRNSNotice of AGM
22nd Mar 20237:00 amRNSFY22 Preliminary Results to 31 December 2022
8th Mar 20239:49 amRNSHolding(s) in Company
8th Feb 20232:56 pmRNSStandard form for notification of major holdings
30th Jan 20234:32 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSFY22 pre-close trading update
17th Jan 20239:45 amRNSStandard form for notification of major holdings
19th Dec 20227:00 amRNSBlock Admission Application
12th Dec 20227:00 amRNSDomenic De Lorenzo to succeed Bill Ronald as Chair
1st Dec 20229:00 amRNSBlock Listing Return
21st Nov 20227:00 amRNSChange Of Nominated Advisor and Corporate Broker
15th Nov 20226:18 pmRNSStandard form for notification of major holdings
1st Nov 20227:00 amRNSTotal Voting Rights
17th Oct 20223:09 pmRNSStandard form for notification of major holdings
4th Oct 202210:25 amRNSDirector/PDMR Shareholding
3rd Oct 20229:00 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSFever-Tree FY22 Interim Results
1st Sep 20227:00 amRNSTotal Voting Rights
24th Aug 202212:06 pmRNSStandard form for notification of major holdings
19th Jul 20229:57 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20224:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.